Answers are grounded in this paper and cite their sources.
Objective To investigate the association between perirenal fat thickness (PRFT) and pathological grade in patients with clear cell renal cell carcinoma (ccRCC), and to evaluate the preoperative predictive value of PRFT combined with systemic inflammatory biomarkers for identifying high-grade ccRCC. Methods We retrospectively reviewed 142 consecutive patients with pathologically confirmed ccRCC who underwent surgical treatment at our institution between January 2022 and December 2025. According to the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading system, patients were classified into a low-grade group (grades 1–2) and a high-grade group (grades 3–4). Clinical characteristics, laboratory parameters, and preoperative computed tomography (CT) images were collected. PRFT was measured on CT scans, while the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) were calculated from routine blood tests. Univariate and multivariable logistic regression analyses were performed to identify factors associated with high-grade pathology. Receiver operating characteristic (ROC) curve analysis was used to assess the predictive performance of each variable. Results A total of 142 ccRCC patients were included in the study, comprising 101 patients (71.1%) with low-grade tumors and 41 patients (28.9%) with high-grade tumors. Compared with the low-grade group, patients with high-grade ccRCC were older and had larger tumors, higher PRFT, elevated NLR, and increased SII levels (all P < 0.05). Multivariable logistic regression analysis identified tumor size (OR = 1.373, 95% CI: 1.048–1.799, P = 0.022), PRFT (OR = 1.149, 95% CI: 1.052–1.255, P = 0.002), and SII (OR = 1.002, 95% CI: 1.000–1.004, P = 0.018) as independent predictors of high-grade ccRCC. ROC analysis demonstrated that the area under the curve (AUC) was 0.663 for PRFT and 0.616 for SII. The combined model incorporating tumor size, PRFT, and SII achieved an improved AUC of 0.750, with a sensitivity of 75.6% and a specificity of 63.4%. In the subgroup of patients with small renal masses (tumor diameter ≤ 4 cm), PRFT remained significantly higher in the high-grade group than in the low-grade group ( P = 0.028). Conclusions PRFT and SII are both associated with high-grade ccRCC. Incorporating PRFT with systemic inflammatory biomarkers and tumor size improves the preoperative identification of high-grade ccRCC. Notably, PRFT retained its predictive value even among patients with small renal masses, suggesting a potential role for PRFT in preoperative risk stratification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: